These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2917679)

  • 1. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy.
    Ortel B; Sivayathorn A; Hönigsmann H
    Dermatologica; 1989; 178(1):39-42. PubMed ID: 2917679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Lenox-Smith I
    J Infect; 1987 Jan; 14(1):90-2. PubMed ID: 3819463
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Bamber MG; Elder AT; Gray JA; Minns RA
    J Infect; 1986 Jul; 13(1):31-3. PubMed ID: 3734464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema multiforme (Stevens-Johnson) precipitated by Fansidar.
    Adams SJ; Broadbent J; Clayden LM; Ridley CM
    Postgrad Med J; 1985 Mar; 61(713):263-4. PubMed ID: 3983064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stevens-Johnson syndrome and granulopenia induced by sulfadoxine-pyrimethamine (Fansidar)].
    Ligthelm RJ; van Zwienen J; Stuiver PC; Djajadiningrat AP
    Ned Tijdschr Geneeskd; 1983 Sep; 127(38):1735-7. PubMed ID: 6633717
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malaria prevention with Fansidar as a cause of Stevens-Johnson syndrome].
    Claréus BW; Hammar H
    Lakartidningen; 1985 Nov; 82(48):4211. PubMed ID: 4079604
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
    Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC
    Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fansidar-induced Stevens-Johnson Syndrome.
    Hornstein OP; Ruprecht KW
    N Engl J Med; 1982 Dec; 307(24):1529-30. PubMed ID: 7144829
    [No Abstract]   [Full Text] [Related]  

  • 10. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
    Phillips-Howard PA; Behrens RH; Dunlop J
    Lancet; 1989 Sep; 2(8666):803-4. PubMed ID: 2571042
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is the use of Fansidar as an antimalarial justified?].
    Olsen VV
    Ugeskr Laeger; 1985 Feb; 147(7):624-5. PubMed ID: 3976083
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract]   [Full Text] [Related]  

  • 13. Transient lupus anticoagulant and fansidar therapy.
    Jeffrey RF
    Postgrad Med J; 1986 Sep; 62(731):893-4. PubMed ID: 3101054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The reliability and side effects of malaria chemoprophylaxis].
    Steffen R; Heusser R
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe cutaneous adverse reactions and sulphadoxine-pyrimethamine in Sabah, Malaysia.
    Lyn PC; Fernandez E
    Med J Aust; 1987 Mar; 146(6):335-6. PubMed ID: 2950306
    [No Abstract]   [Full Text] [Related]  

  • 16. Does chloroquine contribute to the risk of serious adverse reactions to fansidar?
    Rombo L; Stenbeck J; Lobel HO; Campbell CC; Papaioanou M; Miller KD
    Lancet; 1985 Dec; 2(8467):1298-9. PubMed ID: 2866354
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serious side effects of sulfadoxine/pyrimethamine as antimalarials].
    Christensen PK; Loft S; Olsen VV
    Ugeskr Laeger; 1983 Jan; 145(4):245. PubMed ID: 6845486
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythroderma resembling sézary syndrome after treatment with Fansidar and chloroquine.
    Langtry JA; Harper JI; Staughton RC; Barrington P
    Br Med J (Clin Res Ed); 1986 Apr; 292(6528):1107-8. PubMed ID: 2938663
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M; Rombo L; Gustafsson L
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1876. PubMed ID: 6428585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.